Artificial Intelligence in Cancer Care: Legal and Regulatory Dimensions.

Loading...

Date

2021-10

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

6
views
6
downloads

Citation Stats

Attention Stats

Abstract

Considering that artificial intelligence (AI) technologies have the potential to change cancer care, this article discusses the AI features of which oncologist should most be aware.

Department

Description

Provenance

Subjects

Humans, Neoplasms, Artificial Intelligence, Delivery of Health Care

Citation

Published Version (Please cite this version)

10.1002/onco.13862

Publication Info

Gowda, Vrushab, Tendai Kwaramba, Cynthia Hanemann, Jorge A Garcia and Pedro C Barata (2021). Artificial Intelligence in Cancer Care: Legal and Regulatory Dimensions. The oncologist, 26(10). pp. 807–810. 10.1002/onco.13862 Retrieved from https://hdl.handle.net/10161/33512.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Kwaramba

Tendai Kwaramba

Assistant Professor of Medicine

Dr. Tendai Kwaramba is a physician-researcher and medical oncologist specializing in gastrointestinal malignancies and global oncology. Her research centers on improving equitable access to cancer prevention, diagnosis, treatment, and survivorship care in resource-limited settings. She leads an ASCO-Conquer Cancer Young Investigator Award–funded study evaluating the implementation of evidence-based treatment de-escalation strategies for early breast cancer in South Africa. Her work bridges health equity, implementation science, and clinical oncology, with a particular focus on optimizing care delivery and resource utilization in low- and middle-income countries.

At Duke Cancer Institute, Dr. Kwaramba is developing research infrastructure that links cancer registry and precision medicine capacity in East Africa. Her broader scholarly portfolio includes work on cancer survivorship risk modeling, early onset cancers, community engagement, disparities in palliative care delivery, and the inclusion of underrepresented populations in cancer research. Drawing on her multidisciplinary background in global health and oncology, Dr. Kwaramba aims to lead collaborative, data-driven initiatives that reduce disparities and advance equitable cancer outcomes worldwide.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.